PHILADELPHIA, PA-July 7
-Premier Research Group Limited, the international clinical research services company, announced that it has implemented OraclexAE; Remote Data Capture Onsite 4.5.3, the enhanced version of Oracle's EDC application featuring new functionality to meet the needs of trial sponsors as well as investigative site personnel.
Premier Research has a long tradition of Oracle Clinical data management as an early adopter of the platform having first licensed it in 1997. Our global data operation team of more than 245 professionals has managed more than 350 studies using Oracle Clinical including 180 EDC studies.
The system's zero footprint deployment allows sites to rely solely on a web browser without loading or maintaining additional software streamlining system and site management. Electronic case report form (eCRF) pages, developed in HTML, open in two to three seconds. The system requires fewer key strokes to navigate pages, displays all information (captured data, discrepancy and audit information) on a single CRF screen, and allows multiple pages to be opened simultaneously. In addition, the re-architected patient data report offers significant performance gains and is better tailored for use in electronic submissions.
"Oracle RDC Onsite 4.5.3 provides us with powerful new functionality increasing the productivity and efficiency of investigative sites that will result in faster, more accurate data entry and accelerate the clinical trial process for our clients," said Walt Wunder, Executive Director, Global Data Operations for Premier Research.
About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, CNS, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.
Premier Research has 32 offices and operates in more than 30 countries across North America and Europe employing more than 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
MariTide Shows Up to 20% Weight Loss in Phase II Trial for Obesity, Type 2 Diabetes
June 24th 2025In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained weight loss of up to 20% in adults with obesity, with or without type 2 diabetes, alongside notable improvements in glycemic control, supporting its advancement to Phase III studies as a potential once-monthly treatment option.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.